Parallel Advisors LLC lifted its stake in Danaher Co. (NYSE:DHR – Free Report) by 3.4% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,524 shares of the conglomerate’s stock after buying an additional 445 shares during the quarter. Parallel Advisors LLC’s holdings in Danaher were worth $3,379,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Gilbert & Cook Inc. boosted its holdings in Danaher by 4.9% during the fourth quarter. Gilbert & Cook Inc. now owns 1,830 shares of the conglomerate’s stock worth $423,000 after buying an additional 86 shares in the last quarter. Accretive Wealth Partners LLC boosted its stake in shares of Danaher by 12.9% during the 4th quarter. Accretive Wealth Partners LLC now owns 3,632 shares of the conglomerate’s stock worth $840,000 after acquiring an additional 414 shares in the last quarter. Gryphon Financial Partners LLC grew its position in shares of Danaher by 19.1% during the 4th quarter. Gryphon Financial Partners LLC now owns 2,917 shares of the conglomerate’s stock valued at $675,000 after acquiring an additional 468 shares during the period. Jump Financial LLC increased its stake in shares of Danaher by 287.0% in the 4th quarter. Jump Financial LLC now owns 4,625 shares of the conglomerate’s stock valued at $1,070,000 after purchasing an additional 3,430 shares in the last quarter. Finally, Great Lakes Advisors LLC raised its holdings in Danaher by 23.3% in the 4th quarter. Great Lakes Advisors LLC now owns 43,957 shares of the conglomerate’s stock worth $10,169,000 after purchasing an additional 8,317 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Danaher news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Danaher news, CEO Rainer Blair sold 9,007 shares of the company’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $280.00, for a total transaction of $2,521,960.00. Following the transaction, the chief executive officer now directly owns 97,983 shares in the company, valued at $27,435,240. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The disclosure for this sale can be found here. In the last ninety days, insiders sold 39,659 shares of company stock valued at $11,042,433. 11.10% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
View Our Latest Research Report on Danaher
Danaher Price Performance
Danaher stock opened at $274.25 on Friday. The company has a current ratio of 1.43, a quick ratio of 1.04 and a debt-to-equity ratio of 0.33. The company has a 50-day moving average price of $264.55 and a 200 day moving average price of $256.50. Danaher Co. has a 12-month low of $182.09 and a 12-month high of $281.70. The stock has a market cap of $198.07 billion, a P/E ratio of 46.48, a PEG ratio of 4.48 and a beta of 0.83.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.15. The business had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.94% and a return on equity of 11.06%. The business’s revenue was down 2.9% compared to the same quarter last year. During the same quarter last year, the firm earned $2.05 EPS. Sell-side analysts anticipate that Danaher Co. will post 7.59 earnings per share for the current year.
Danaher Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Friday, September 27th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.39%. The ex-dividend date of this dividend is Friday, September 27th. Danaher’s dividend payout ratio is presently 18.31%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- What does consumer price index measure?
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- What Are Some of the Best Large-Cap Stocks to Buy?
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- MarketBeat Week in Review – 9/9 – 9/13
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.